860169-77-3

Basic information

• Product Name: 1-Piperidinehexanoic acid, 4-[bis(phenylmethyl)amino]-3-methoxy-, ethyl ester, (3S,4R)-
• CAS NO: 860169-77-3
• Molecular Formula: C28H40N2O3
• Molecular Weight: 452.637
• Mol File: 860169-77-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-Piperidinehexanoic acid, 4-[bis(phenylmethyl)amino]-3-methoxy-, ethyl ester, (3S,4R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinehexanoic acid, 4-[bis(phenylmethyl)amino]-3-methoxy-, ethyl ester, (3S,4R)-(860169-77-3)
• EPA Substance Registry System: 1-Piperidinehexanoic acid, 4-[bis(phenylmethyl)amino]-3-methoxy-, ethyl ester, (3S,4R)-(860169-77-3)

Safety Data

• Hazardous Substances Data: 860169-77-3(Hazardous Substances Data)

Upstream product

• 83898-43-5 ethyl 3-hydroxy-4,4-dimethoxy-1-piperidinecarboxylate 
• 103-49-1 dibenzylamine 
• 29976-53-2 N-ethoxycarbonyl-4-piperidone 
• 83863-72-3 (-)-ethyl 3-methoxy-4-oxo-1-piperidine-carboxylate 
• 83863-73-4 (-)-ethyl 3,4,4-trimethoxy-1-piperidinecarboxylate 
• 100-39-0 benzyl bromide 
• 83863-71-2 C₉H₁₈N₂O₃*ClH 
• 1000027-12-2 N,N-dibenzyl-3-methoxypiperidin-4-amine 
• 1000027-11-1 ethyl 4-(dibenzylamino)-3-methoxypiperidine-1-carboxylate 
• 128225-42-3 ethyl 4-amino-3-methoxy-1-piperidinecarboxylate 
• 860169-74-0 (3S,4R)-N,N-dibenzyl-3-methoxypiperidin-4-amine 
• 25542-62-5 6-bromo-hexanoic acid ethyl ester 

Downstream Products

• 860169-80-8 (R)-quinuclidin-3-yl 6-((3S,4R)-4-(dibenzylamino)-3-methoxypiperidin-1-yl)hexanoate 

Relevant articles and documents

LUMINALLY-ACTING N-(PIPERIDIN-4-YL)BENZAMIDE DERIVATIVES

Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein m, R1, R2, R3, R4, R5, R6, X1, X2, X3 and X4 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating diseases, disorders, and conditions associated with the 5-HT4 receptor.

SYNTHETIC METHODS AND INTERMEDIATES FOR STEREOISOMERIC COMPOUNDS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS

The subject invention provides methods and/or processes for making stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including,

STEREOISOMERIC COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS

The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis,